Click here to view an updated version of this article.

NEW YORK, June 24 - Celera Diagnostics and Abbott Labs will partner to develop and market a "broad range" of in vitro molecular diagnostics to detect and monitor a variety of diseases, the companies said today.


To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

Magdalena Skipper, the incoming editor-in-chief of Nature, speaks with NPR's Weekend Edition Sunday.

Genetic genealogy has led to an arrest in another cold case, dating back to 1987.

In PLOS this week: mutation in second gene widens clinical symptoms of people with ADD3 mutations, comparative genomic analysis of Pseudovibrio, and more.

Wired reports that 23andMe is trying to bolster its outside collaborations.